Pancreatic Cancer Research

ResearcherAmsterdam University Medical CentersActive in the last 2 years

Paul Manoukian

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-1130-8582; OpenAlex author ID A5124702872. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 2 papers · 2026: 2 papers

Papers 8

  1. Transcriptome-Based Classification of Resected Pancreatic Ductal Adenocarcinoma Enhances Prognostic Modelling Accuracy of Overall Survival Following Adjuvant T… Co-author DOI 10.1002/ijc.70519↗
  2. Estrogen Production in Pancreatic Cancer Shapes a Tumor-Suppressive Stromal Microenvironment. Co-author DOI 10.1158/0008-5472.can-24-4707↗
  3. Association of epigenetic landscapes with heterogeneity and plasticity in pancreatic cancer. Co-author DOI 10.1016/j.critrevonc.2024.104573↗
  4. Stromal Hedgehog Signaling Is Associated with Favorable Outcomes in Pancreatic Cancer. Co-author DOI 10.3390/ijms26115200↗
  5. Transcriptome-based classification to predict FOLFIRINOX response in a real-world metastatic pancreatic cancer cohort. Co-author DOI 10.1016/j.trsl.2024.08.002↗
  6. Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer. First author DOI 10.1002/ijc.34276↗
  7. Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2023.112581↗
  8. The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth. Co-author DOI 10.3389/fcell.2021.743907↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maarten F. Bijlsma · 8 shared papers, 2021–2026 · strength 1.86
  2. Hanneke W.M. van Laarhoven · 7 shared papers, 2021–2026 · strength 1.70
  3. Marjolein F. Lansbergen · 3 shared papers, 2024–2026 · strength 0.65
  4. Johanna W. Wilmink · 3 shared papers, 2024–2026 · strength 0.65
  5. Mark P.G. Dings · 3 shared papers, 2023–2026 · strength 0.56
  6. Geert Kazemier M · 2 shared papers, 2026 · strength 0.46
  7. Joanne Verheij · 2 shared papers, 2024–2026 · strength 0.41
  8. Frederike Dijk · 2 shared papers, 2024–2026 · strength 0.41
  9. Ignace H. J. T. de Hingh · 2 shared papers, 2023–2026 · strength 0.36
  10. Marc G. Besselink · 2 shared papers, 2023–2026 · strength 0.36
  11. Casper H.J. van Eijck · 2 shared papers, 2023–2026 · strength 0.36
  12. Lan Zhao · 1 shared paper, 2025 · strength 0.33
  13. Helene Damhofer · 1 shared paper, 2025 · strength 0.33
  14. Nienke Petronella Maria Wassenaar · 1 shared paper, 2026 · strength 0.24
  15. Vincent Erwin de Meijer · 1 shared paper, 2026 · strength 0.23
  16. Martijn W.J. Stommel · 1 shared paper, 2026 · strength 0.23
  17. Giulia Mantini · 1 shared paper, 2023 · strength 0.16
  18. Andrea Vallés‐Martí · 1 shared paper, 2023 · strength 0.16
  19. Elisa Giovannetti · 1 shared paper, 2023 · strength 0.16
  20. Connie R. Jiménez · 1 shared paper, 2023 · strength 0.16
  21. Sophie C. Lodestijn · 1 shared paper, 2023 · strength 0.14
  22. Izaak Quintus Molenaar · 1 shared paper, 2023 · strength 0.14
  23. Nadia Haj Mohammad · 1 shared paper, 2023 · strength 0.14
  24. Louis Vermeulen · 1 shared paper, 2023 · strength 0.14
  25. Michail Doukas · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.